Clinical update on the use of prazosin for night-time symptoms of PTSD
Published online on May 06, 2026
Abstract
Australasian Psychiatry, Ahead of Print.
ObjectiveTo provide a clinical update on the treatment of night-time symptoms of posttraumatic stress disorder (PTSD) with prazosin, which is a centrally acting alpha-1 adrenergic receptor antagonist.MethodsWe performed a narrative review of the relevant ...
ObjectiveTo provide a clinical update on the treatment of night-time symptoms of posttraumatic stress disorder (PTSD) with prazosin, which is a centrally acting alpha-1 adrenergic receptor antagonist.MethodsWe performed a narrative review of the relevant ...